Category: Generics Drugs
Europe Generics Drugs
-
Antiviral Drugs Market, By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, and Others), By Type (Branded and Generics), By Application (HIV, Hepatitis, Herpes, Influenza, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... been witnessing steady growth over the past few years. Antiviral drugs, also known as antiviral agents or anti-infective medications, are a class of medication used specifically for treating infections caused by viruses. They work by ... Read More
-
Europe Specialty Generics Market Report by Route of Administration (Injectables, Oral, and Others), Indication (Oncology, Autoimmune Diseases, Infectious Diseases, and Others), Distributional Channel (Retail Pharmacies, Specialty Pharmacies, Hospital Pharmacies), and Region 2025-2033
... The increasing prevalence of chronic diseases, rising demand for affordable medicines, and implementation of favorable regulatory guidelines are some of the key factors driving the market. Specialty generics refer to complex, difficult-to-produce medications that are ... Read More
-
Pharmaceutical Glass Packaging Market Research Report Information by Product Type (Vials, Bottles & Jars, Cartridges & Syringes, Ampoules), by Material Type (Type I, Type II, Type III), by Application (Generic Drugs, Branded Drugs, Biological Drugs), and by Region (North America, Europe, Asia-Pacific, Middle East & Africa, and South America) Market Industry Forecast Till 2032
... and by Region (North America, Europe, Asia-Pacific, Middle East & Africa, and South America) Market Industry Forecast Till 2032 In 2023, the pharmaceutical glass packaging market was estimated to be worth USD 21,354.2 million. According ... Read More
-
Generics in Scandinavia
... key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both ... Read More
-
Generics in the United Kingdom
... descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by ... Read More
-
Generics in Italy
... the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that ... Read More
-
Generics in Spain
... the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that ... Read More
-
Generics in France
... the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that ... Read More
-
Generics in Germany
... key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both ... Read More
-
Generics in the Netherlands
... players including key financial metrics and analysis of competitive pressures within the market. Key Highlights A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now ... Read More
-
Pharmaceutical Contract Manufacturing Market by Type of Product Manufactured (API & Intermediates and FDF), Type of API (Originator API and Generic API), API Potency (Low Potent API and High Potent API), Type of FDF (Originator FDF and Generic FDF), Dosage Form (Oral Solids, Liquids, Emulsions and Other Dosage Forms), Type of Packaging Offered (Bottles, Blister, Parenteral and Others), Scale of Operation (Clinical and Commercial), End Users (Small, Mid-sized, and Large and Very Large Companies) and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and North Africa): Industry Trends and Global Forecasts, Till 2035
... FDF and Generic FDF), Dosage Form (Oral Solids, Liquids, Emulsions and Other Dosage Forms), Type of Packaging Offered (Bottles, Blister, Parenteral and Others), Scale of Operation (Clinical and Commercial), End Users (Small, Mid-sized, and Large ... Read More
-
Fill Finish Pharmaceutical Contract Manufacturing Market by Type of Fill Finish Service Offered (Aseptic Filling, Blow-Fill-Seal and Terminal Sterilization), Type of FDF (Generic FDF and Originator FDF), API Potency (Low Potent API and High Potent API), Type of Primary Packaging Container (Ampoules, Cartridges, Prefilled Syringe, Vials and Other Containers), Scale of Operation (Clinical and Commercial), Company Size (Small and Mid-sized Companies, Large / Very Large Companies) and Geographical Regions (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest of the World) and Leading Players: Industry Trends and Global Forecasts, Till 2035
... API), Type of Primary Packaging Container (Ampoules, Cartridges, Prefilled Syringe, Vials and Other Containers), Scale of Operation (Clinical and Commercial), Company Size (Small and Mid-sized Companies, Large / Very Large Companies) and Geographical Regions (North ... Read More
-
2024 Germany Inhalation And Nasal Sprays Generic Drugs Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... is within the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on ... Read More
-
2024 France Inhalation And Nasal Sprays Generic Drugs Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... is within the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on ... Read More
-
2024 Europe Inhalation And Nasal Sprays Generic Drugs Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... is within the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on ... Read More
-
2024 United Kingdom Inhalation And Nasal Sprays Generic Drugs Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... category is within the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates ... Read More
-
GCC Generic Drug Market: Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on GCC generic drug market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the GCC generic ... Read More
-
Pharmaceuticals in the United Kingdom: ISIC 2423
... ISIC 2423 market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of ... Read More
-
Generic Drugs Market Research Report Information by Type (Simple Generics and Super Generics), by Brand (Pure Generic and Branded Generic), by Indication (Central Nervous System (CNS), Cardiovascular, Urology, Oncology, Respiratory, and Others), by Route of Administration (Oral, Topical, Parenteral, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Europe, Asia-Pacific, and Rest of the World – Industry Forecast till 2032
... Administration (Oral, Topical, Parenteral, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Europe, Asia-Pacific, and Rest of the World – Industry Forecast till 2032 In 2023, ... Read More
-
Europe Generic Drugs Market Report and Forecast 2024-2032
... at a CAGR of 7.0% during the forecast period of 2024-2032, driven by growing focus on biosimilars. The market is experiencing robust growth and is expected to reach USD 161.7 billion by 2032. Europe Generic ... Read More
-
India and Europe Generic Injectable Market - Industry Trends and Forecast to 2035
... a CAGR of 9.0% in the forecast period of 2024 to 2035. The India generic injectable market is expected to reach USD 19,298.93 million by 2035 from USD 7,128.62 million in 2023, growing with a ... Read More
-
Pharmaceutical Contract Manufacturing (3rd Edition), 2021-2030 Distribution by [A] business segment (API and FDF), [B] type of API (branded and generic), [C] type of FDF (oral solids, parenteral and others), [D] type of packaging form (blisters, bottles, injectables and others), [E] scale of operation (clinical and commercial), [F] end-users (large pharmaceutical companies, mid-sized pharmaceutical companies and small pharmaceutical companies) and [G] key geographical regions (North America, Europe, Asia-Pacific, Latin America, and Middle-East and North Africa): Industry Trends and Global Forecasts
... (blisters, bottles, injectables and others), [E] scale of operation (clinical and commercial), [F] end-users (large pharmaceutical companies, mid-sized pharmaceutical companies and small pharmaceutical companies) and [G] key geographical regions (North America, Europe, Asia-Pacific, Latin America, ... Read More
-
G8 Countries Generics Market Summary, Competitive Analysis and Forecast to 2027
... The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights G8 countries contributed $149,123.6 million in 2022 to the global generics industry, ... Read More
-
Germany Pharmaceutical 3PL Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... billion by 2028, at a CAGR of 4.47% during the forecast period (2023-2028). Key Highlights COVID-19 obviously had a positive impact on the market. The German pharmaceutical market's clinic and pharmacy section had grown by ... Read More
-
France Generics Market Summary, Competitive Analysis and Forecast to 2027
... contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, a generic drug is defined as a copy of ... Read More
Research Assistance
